Clinical VX-880 trial improves blood sugar control in all treated patients, with three achieving insulin independence
Six adults with type 1 diabetes (T1D) treated with stem cell-derived islet cells (VX-880) have shown improved blood sugar control, with three participants achieving insulin independence, according to new research being presented ...